Inadequate dietary magnesium intake increases atherosclerotic plaque development in rabbits

Nutrition Research

Volumn 29, Issue 5, 2009, Pages 343-349

  King, Jennifer L ^a,b   Miller, Rita J ^a   Blue Jr , James P ^a   O'Brien Jr , William D ^a,b   Erdman Jr , John W ^b  

^a University of Illinois at Urbana Champaign   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Atherosclerosis; C reactive protein; Cholesterol; Magnesium; Rabbit

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; ERYTHROCYTE; MAGNESIUM BLOOD LEVEL; MALE; NONHUMAN; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RABBIT; RISK ASSESSMENT; RISK FACTOR;

ANIMALS; AORTA; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CHOLESTEROL; DIET; ERYTHROCYTES; MAGNESIUM; MAGNESIUM DEFICIENCY; RABBITS; TRIGLYCERIDES; TUNICA INTIMA;

ORYCTOLAGUS CUNICULUS;

EID: 67449155784     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2009.05.001     Document Type: Article

References (34)

1. Ford E.S., and Mokdad A.H. Dietary magnesium intake in a national sample of US adults. J Nutr. 133 9 (2003) 2879-2882
2. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. In: Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, and Institute of Medicine (Ed). Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. 1997th ed. (1997), National Academy Press, Washington, DC
3. American Heart Association. Heart disease and stroke statistics, 2005 update (2005), American Heart Association
4. Kannel B., and Larson M. Long-term epidemiologic prediction of coronary disease: the Framingham experience. Cardiology 82 (1993) 137-152
5. Fruchart J.C., Nierman M.C., Stroes E.S., Kastelein J.J., and Duriez P. New risk factors for atherosclerosis and patient risk assessment. Circulation 109 23 Suppl 1 (2004) III15-III19
6. Ma J., Folsom A.R., Melnick S.L., Eckfedlt J.H., Sharrett A.R., Nabulsi A.A., et al. Association of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. J Clin Epidemiology 48 (1995) 927-940
7. Leone N., Courbon D., Ducimetiere P., and Zureik M. Zinc, copper, and magnesium and risks for all cause, cancer, and cardiovascular mortality. Epidemiology 17 3 (2006) 308-314
8. Shechter M., Sharir M., Labrador M.J., Forrester J., Silver B., and Bairey Merz C.N. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation 102 19 (2000) 2353-2358
9. Abraham A.S., Weinstein M., Eylath U., and Czaczkes E. Magnesium levels in patients with chronic ischemic heart disease. Am J Clin Nutr 31 8 (1978) 1400-1402
10. Song Y., Manson J., Cook N., Albert C., Buring J., and Liu S. Dietary magnesium intake and risk of cardiovascular disease among women. Am J Cardiol 96 (2005) 1135-1141
11. Amighi J., Sabeti S., Schlager O., Mlekusch W., Exner M., Lalouschek W., et al. Low serum magnesium predicts neurological events in patients with advanced atherosclerosis. Stroke 35 1 (2004) 22-27
12. Mahfouz M.M., Zhou Q., and Kummerow F.A. Cholesterol oxides in plasma and lipoproteins of magnesium-deficient rabbits and effects of their lipoproteins on endothelial barrier function. Magnes Res 7 3-4 (1994) 207-222
13. King D.E., Mainous III A.G., Geesey M.E., and Woolson R.F. Dietary magnesium and C-reactive protein levels. J Am Coll Nutr 24 3 (2005) 166-171
14. Altura B.M., Gebrewold A., Altura B.T., and Brautbar N. Magnesium depletion impairs myocardial carbohydrate and lipid metabolism and cardiac bioenergetics and raises myocardial calcium content in vivo: relationship to etiology of cardiac diseases. Biochem Mol Bio Int 40 (1996) 1183-1190
15. Shivakumar K. Model of cardiovascular injury in magnesium deficiency. Med Hypotheses 56 (2001) 110-113
16. Yanni A.E. The laboratory rabbit: an animal model of atherosclerosis research. Lab Anim 38 3 (2004) 246-256
17. Maier J.A. Low magnesium and atherosclerosis: an evidence-based link. Mol Aspects Med 24 1-3 (2003) 137-146
18. Altura B.T., Brust M., Bloom S., Barbour R.L., Stempak J.G., and Altura B.M. Magnesium dietary intake modulates blood lipid levels and atherogenesis. Proc Natl Acad Sci U S A 87 5 (1990) 1840-1844
19. Ouchi Y., Tabata R.E., Stergiopoulos K., Sato F., Hattori A., and Orimo H. Effect of dietary magnesium on development of atherosclerosis in cholesterol-fed rabbits. Arteriosclerosis 10 5 (1990) 732-737
20. National Research Council. Nutrient requirements of rabbits. 2nd ed. (1977), National Academy of Sciences, Washington, DC, USA
21. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226 1 (1957) 497-509
22. Hein J., and Hartmann K. Reference ranges for laboratory parameters in rabbits. Tierarztliche Praxis Ausgabe Kleintiere Heimtiere 31 5 (2003) 321-328
23. Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347 (2002) 1557-1565
24. Clifton P.M. Diet and C-reactive protein. Curr Atheroscler Rep 5 6 (2003) 431-436
25. Nan B., Yang H., Yan S., Lin P., Lumsden A., Yao Q., et al. C-reactive protein decreases expression of thrombomodulin and endothelial protein C receptor in human endothelial cells. Surgery. 138 2 (2005) 212-222
26. Randell E.W., Mathews M., Gadag V., Zhang H., and Sun G. Relationship between serum magnesium values, lipids, and anthropometric risk factors. Atherosclerosis 196 1 (2008) 413-419
27. Inoue I. Lipid metabolism and magnesium. Clin Calcium 15 11 (2005) 65-76
28. Fujii H. Nuclear Receptor PPARs and magnesium. Clin Calcium 15 11 (2005) 52-64
29. Nozue T., Ide N., Okabe H., Narui K., and Kobayashi A. Correlation of serum HDL-cholesterol and LCAT levels with the fraction of ionized magnesium in children. Magnes Res 12 4 (1999) 297-301
30. Wang X., Greilberger J., and Jurgens G. Calcium and lipoprotein lipase synergistically enhance the binding and uptake of native and oxidized LDL in mouse peritoneal macrophages. Atherosclerosis 150 (2000) 357-363
31. Zhang W., and Xu C. Calcium sensing receptor and heart diseases. Pathophysiology (2009) [Article in press]
32. Maier J.A., Malpuech-Brugere C., Zimowska W., Rayssiguier Y., and Mazur A. Low magnesium promotes endothelial cell dysfunction: Implications for atherosclerosis, inflammation and thrombosis. Biochim Biophys Acta 1689 1 (2004) 13-21
33. Mason R. Atheroprotective effects of long-acting dihydropyridine-type calcium channel blockers: evidence from clinical trials and basic scientific research. Cerebrovasc Dis 16 suppl 3 (2003) 11-17
34. Constans J., and Conri C. Circulation markers of endothelial function in cardiovascular disease. Con Chim Acta 368 1-2 (2006) 33-47